Dermatitis
Seborrheic Dermatitis
search
Seborrheic Dermatitis
, Seborrhea, Dandruff
See Also
Pediatric Seborrheic Dermatitis
(
Cradle Cap
)
Epidemiology
Prevalence
Gene
ral population: 1-3%
Immunocompromised
: >34%
Gender
More common in men
Age (bimodal)
Age 2 to 12 months
Adolescent and young adult
Pathophysiology
Altered skin cell functioning
Results in skin inflammation with redness, itching and
Scaling
Associated with fungal overgrowth
Normal skin colonization with the fungus Malassezia species (Malassezia furfur, Malassezia ovalis)
Malassezia invade
Stratum Corneum
in Seborrheic Dermatitis
Release
Lipase
s that in turn result in free
Fatty Acid
formation
Free
Fatty Acid
s allow for increased Malassezia growth and cause the localized skin inflammation
Stratum Corneum
proliferates in response to inflammation and results in
Scaling
Stratum Corneum
is also impaired as a barrier allowing for further Malassezia invasion
Causes
Idiopathic (most cases)
Risk Factors
Immunocompromised
state (e.g.
AIDS
)
Increased emotional stress
Cold, dry environments
Sun Exposure
Associated Conditions
Acquired Immunodeficiency Syndrome
(
AIDS
)
Nutritional deficiency
Impaired essential
Fatty Acid Metabolism
Neurologic conditions
Parkinsonism
Cerebrovascular Accident
(CVA)
Epilepsy
Symptoms
Greasy,
Scaling
rash on the face and scalp
Pruritus
Signs
See
Pediatric Seborrheic Dermatitis
(
Cradle Cap
)
Characteristics
Flaky,
Scaling
lesions with underlying erythematous patches
Scaling
Greasy or oily skin
Distribution
Common areas
Scalp
Nasolabial fold
Facial involvement (T-distribution)
Central face
Beard area
Eyebrows
Chest
involvement
Under the
Breast
Petaloid Seborrhea (flower petal-like)
Red-brown
Papule
s with scale
Papule
s evolve into contiguous patches
Pityriasiform Seborrhea (
Pityriasis Rosea
-like)
Gene
ralized
Macule
s and patches
Associated skin findings
Blepharitis
Otitis Externa
Acne Vulgaris
Pityriasis Versicolor
Labs
Biopsy (indicated only in unclear diagnosis)
Scale crust with
Neutrophil
s (perifollicular)
Epidermal parakeratosis
Plugged follicular ostia
Spongiosis
Differential Diagnosis
Acne Rosacea
Atopic Dermatitis
Candidiasis
Contact Dermatitis
Dermatophytosis
Erythrasma
Impetigo
Langerhans Cell Histiocytosis
Lichen Simplex Chronicus
Nummular
Eczema
Pityriasis Rosea
Psoriasis
vulgaris
Rosacea
Secondary Sypilis
Systemic Lupus Erythematosus
Tinea Capitis
or
Tinea Corporis
Pediculosis Ciliaris
(eyelash lice)
Uremic frost
Occurs in end-stage renal disease with high BUN (untreated or missed
Hemodialysis
)
Crystallized urea from sweat forms and deposits on the skin
Management
Scalp
Approach
Gene
ral
Massage the
Shampoo
into the scalp and leave on for 5 minutes before rinsing
Start with 2-3 times weekly use for several weeks until remission
Maintain control with once weekly use
Change to alternative product if one stops working after months of use
Fungal resistance may develop to a single product
Mild scalp involvement
Use over-the-counter
Antifungal
preparations
Moderate scalp involvement
Start with prescription
Antifungal
Shampoo
2-3 times weekly for several weeks until remission
Maintain control with once weekly use
Consider medium potency
Corticosteroid
intermittent, short-term use for itching, inflammation
Moderate to severe scalp involvement
High potency
Corticosteroid
(Clobetasol) twice weekly (wean as inflammation resolves)
Ketaconazole 2%
Shampoo
twice weekly
Topical Antifungal
s (Over-The-Counter)
Coal Tar
Shampoo
twice weekly
Selenium
sulfide
Shampoo
(e.g. selsun blue moisturizing) twice weekly
Tea tree oil
Shampoo
daily
Zinc
pyrithione 1%
Shampoo
(e.g. head and
Shoulder
classic) twice weekly
Ketoconazole
1% (
Nizoral
)
Shampoo
Topical Antifungal
Shampoo
s (prescription)
Apply to hair for at least 5 minutes before washing out
Ketoconazole
2% (
Nizoral
)
Shampoo
Start with daily use, then twice weekly
Ciclopirox
1%
Shampoo
(
Loprox
)
Start with daily use, then twice weekly
Topical Corticosteroid
s
Medium potency
Topical Corticosteroid
s
Betamethasone valerate
0.12% foam (Luxiq) applied daily to twice daily
Fluocinolone 0.01%
Shampoo
(e.g. Capex) or solution (e.g.
Synalar
) applied daily
High potency
Topical Corticosteroid
s
Clobetasol 0.05%
Shampoo
(Clobex) twice weekly
Management
Face and Body
Approach
Maintenance:
Topical Antifungal
s
Topical Antifungal
s are first-line therapy for face and body Seborrhea
As effective as
Corticosteroid
s and safe for longterm use
Inflammation or flare-ups (intermittent and short-term use)
Topical Corticosteroid
s
Calcineurin Inhibitor
s
Topical Antifungal
s
Ketoconazole
2% cream (
Nizoral
), gel (Xolegel) or foam (
Extina
)
Twice daily for up to 8 weeks, then as needed
Most reasonably priced
Ciclopirox
0.77% gel or 1% cream (Ciclodan, not available in U.S.)
Twice daily for up to 4 weeks
Sertaconazole 2% cream (Ertaczo)
Twice daily for up to 4 weeks
Very expensive ($423 for 60 grams in 2014)!
Topical
Calcineurin Inhibitor
s
See specific medications for precautions
FDA black box warning for
Lymphoma
and
Skin Cancer
risk
Tacrolimus
0.1% ointment (
Protopic
)
Twice daily
Pimecrolimus
1% cream (
Elidel
)
Twice daily
Topical Corticosteroid
s
Medium potency
Topical Corticosteroid
s
Betamethasone valerate
0.1% cream (Beta-Val) or lotion applied once or twice daily
Fluocinolone 0.01% cream, oil (Derma Smoothe) or solution (
Synalar
) applied once to twice daily
Low potency
Topical Corticosteroid
s
Hydrocortisone
1% cream or ointment
Desonide
Forms: 0.05% cream, foam (Verdeso), gel (Desonate), lotion (Lokara) or ointment (
Desowen
)
Apply once or twice daily
Preparations
Anti-inflammatory agents
Decrease the skin inflammatory response (see pathophysiology above)
Topical Corticosteroid
s
High potency
Topical Corticosteroid
s (for scalp)
Clobetasol 0.05%
Shampoo
(Clobex) twice weekly to scalp
Medium potency
Topical Corticosteroid
s
Betamethasone valerate
Scalp: 0.1% lotion or 0.12% foam applied daily
Face or body: 0.1% cream (Beta-Val) or lotion applied once or twice daily
Fluocinolone
Scalp: 0.01%
Shampoo
(e.g. Capex) or solution (e.g.
Synalar
) applied daily
Face or body: 0.01% cream, oil (Derma Smoothe) or solution (
Synalar
) applied once to twice daily
Low potency
Topical Corticosteroid
s (for face or body)
Hydrocortisone
1% cream or ointment
Desonide
0.05% cream, foam (Verdeso), gel (Desonate), lotion (Lokara) or ointment (
Desowen
) 1-2x daily
Topical
Calcineurin Inhibitor
s (for face and body involvement)
Tacrolimus
0.1% ointment (
Protopic
)
Twice daily
Pimecrolimus
1% cream (
Elidel
)
Twice daily
Preparations
Keratolytic
s
Remove outer layers of the hyperproliferating
Stratum Corneum
(see pathophysiology above)
Indicated for scalp or beard area
Directions
Apply 2-3 times weekly
Leave
Shampoo
s applied to scalp for 5 minutes
Types
Salicylic acid 2-3% to remove scalp crusts
Tar
Shampoo
Zinc
pyrithione applied daily to 4 times daily
Preparations
Antifungal
s
Suppress the Malassezia fungus population (see pathophysiology above)
Ketoconazole
2%
Scalp: (
Nizoral
)
Shampoo
, starting with daily use, then twice weekly
Face and body: Cream (
Nizoral
), gel (Xolegel) or foam (
Extina
) twice daily for 8 weeks
Effective for face
Of the
Antifungal
s, most reasonably priced, and cream is best tolerated
Ciclopirox
Scalp: 1%
Shampoo
(
Loprox
) starting with daily use, then twice weekly
Face and body: 0.77% gel or cream (Ciclodan) twice daily for up to 4 weeks
Sertaconazole 2% cream (Ertaczo)
Indicated for face and body involvement
Twice daily for up to 4 weeks
Very expensive ($423 for 60 grams in 2014)!
Selenium
sulfide 2.5% (Selsun)
Tea Tree Oil
Shampoo
(5%)
Antifungal
activity
Effective and well tolerated
Satchell (2002) J Am Acad Dermatol 47:852-5 [PubMed]
Other anti-fungals
Fluconazole
topically
Oral anti-fungals (
Terbinafine
) have been used
Preparations
Combination therapies
Triple cream compounded at pharmacy
Salicylic acid 2%
Hydrocortisone
0.05%
Precipitated Sulfur
3%
Moderate scalp involvement combination
Chloroxine 2%
Shampoo
apply daily
Flucinolone 0.01% solution apply to scalp qd to bid
References
(2022) Presc Lett 29(7): 39
Clark (2015) Am Fam Physician 91(3): 185-90 [PubMed]
Danby (1993) J Am Acad Dermatol 29:1008-12 [PubMed]
Gupta (2004) Dermatology 208:89-93 [PubMed]
Scwartz (2006) Am Fam Physician 74:125-30 [PubMed]
Type your search phrase here